Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.

Krauth MT, Burgstaller S, Buxhofer-Ausch V, Gastl G, Geissler K, Keil F, Krippl P, Melchardt T, Petzer A, Rumpold H, Sliwa T, Wöhrer S, Wölfler A, Gisslinger H.

Wien Klin Wochenschr. 2019 Jan;131(1-2):47. doi: 10.1007/s00508-018-1428-7.

PMID:
30542777
2.

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Krauth MT, Burgstaller S, Buxhofer-Ausch V, Gastl G, Geissler K, Keil F, Krippl P, Melchardt T, Petzer A, Rumpold H, Sliwa T, Wöhrer S, Wölfler A, Gisslinger H.

Wien Klin Wochenschr. 2018 Sep;130(17-18):495-504. doi: 10.1007/s00508-018-1365-5. Epub 2018 Jul 24. Erratum in: Wien Klin Wochenschr. 2019 Jan;131(1-2):47.

3.

Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement.

Sliwa T, Beham-Schmid C, Burgstaller S, Buxhofer-Ausch V, Gastl G, Geissler K, Krauth M, Krippl P, Lang A, Petzer A, Wöhrer S, Wölfler A, Gisslinger H.

Wien Klin Wochenschr. 2017 May;129(9-10):293-302. doi: 10.1007/s00508-016-1120-8. Epub 2016 Dec 13.

PMID:
27966016
4.

Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.

Feistritzer HJ, Reinstadler SJ, Klug G, Reindl M, Wöhrer S, Brenner C, Mayr A, Mair J, Metzler B.

BMC Cardiovasc Disord. 2016 Nov 28;16(1):239.

5.

A Tetrahymena Hsp90 co-chaperone promotes siRNA loading by ATP-dependent and ATP-independent mechanisms.

Woehrer SL, Aronica L, Suhren JH, Busch CJ, Noto T, Mochizuki K.

EMBO J. 2015 Feb 12;34(4):559-77. doi: 10.15252/embj.201490062. Epub 2015 Jan 14.

6.

Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.

Raderer M, Wöhrer S, Kiesewetter B, Dolak W, Lagler H, Wotherspoon A, Muellauer L, Chott A.

Ann Hematol. 2015 Jun;94(6):969-73. doi: 10.1007/s00277-014-2298-3. Epub 2015 Jan 13.

PMID:
25579756
7.

Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients.

Kiesewetter B, Lukas J, Kuchar A, Mayerhoefer ME, Streubel B, Lagler H, Müllauer L, Wöhrer S, Fischbach J, Raderer M.

PLoS One. 2014 Jul 31;9(7):e104004. doi: 10.1371/journal.pone.0104004. eCollection 2014.

8.

Clofarabine/cyclophosphamide for debulking before stem cell transplantation.

Rabitsch W, Böhm A, Bojic M, Schellongowski P, Wöhrer S, Sliwa T, Keil F, Worel N, Greinix H, Hauswirth A, Kalhs P, Jaeger U, Valent P, Sperr WR.

Eur J Clin Invest. 2014 Aug;44(8):775-83. doi: 10.1111/eci.12294.

PMID:
24942362
9.

Distinct stromal cell factor combinations can separately control hematopoietic stem cell survival, proliferation, and self-renewal.

Wohrer S, Knapp DJ, Copley MR, Benz C, Kent DG, Rowe K, Babovic S, Mader H, Oostendorp RA, Eaves CJ.

Cell Rep. 2014 Jun 26;7(6):1956-67. doi: 10.1016/j.celrep.2014.05.014. Epub 2014 Jun 6.

10.

Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.

Wöhrer S, Kiesewetter B, Fischbach J, Müllauer L, Troch M, Lukas J, Mayerhoefer ME, Raderer M.

Ann Hematol. 2014 Aug;93(8):1287-95. doi: 10.1007/s00277-014-2042-z. Epub 2014 Mar 15.

PMID:
24633660
11.

The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells.

Copley MR, Babovic S, Benz C, Knapp DJ, Beer PA, Kent DG, Wohrer S, Treloar DQ, Day C, Rowe K, Mader H, Kuchenbauer F, Humphries RK, Eaves CJ.

Nat Cell Biol. 2013 Aug;15(8):916-25. doi: 10.1038/ncb2783. Epub 2013 Jun 30.

PMID:
23811688
12.

Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview.

Bojic M, Willinger B, Rath T, Tobudic S, Thalhammer F, Böhm A, Mitterbauer M, Schulenburg A, Wöhrer S, Kalhs P, Rabitsch W.

Mycoses. 2013 Nov;56(6):687-9. doi: 10.1111/myc.12087. Epub 2013 May 15. Review.

PMID:
23672484
13.

Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implications.

Valent P, Bonnet D, Wöhrer S, Andreeff M, Copland M, Chomienne C, Eaves C.

Cancer Res. 2013 Feb 1;73(3):1037-45. doi: 10.1158/0008-5472.CAN-12-3678. Epub 2013 Jan 23. Review.

14.

Long-term culture-initiating cell assay for mouse cells.

Woehrer S, Miller CL, Eaves CJ.

Methods Mol Biol. 2013;946:257-66. doi: 10.1007/978-1-62703-128-8_16.

PMID:
23179837
15.

Cancer stem cell definitions and terminology: the devil is in the details.

Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, Roesch A, Schuurhuis GJ, Wöhrer S, Arock M, Zuber J, Cerny-Reiterer S, Johnsen HE, Andreeff M, Eaves C.

Nat Rev Cancer. 2012 Nov;12(11):767-75. doi: 10.1038/nrc3368. Epub 2012 Oct 11. Review.

PMID:
23051844
16.

Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs.

Benz C, Copley MR, Kent DG, Wohrer S, Cortes A, Aghaeepour N, Ma E, Mader H, Rowe K, Day C, Treloar D, Brinkman RR, Eaves CJ.

Cell Stem Cell. 2012 Mar 2;10(3):273-83. doi: 10.1016/j.stem.2012.02.007.

17.

High-throughput analysis of single hematopoietic stem cell proliferation in microfluidic cell culture arrays.

Lecault V, Vaninsberghe M, Sekulovic S, Knapp DJ, Wohrer S, Bowden W, Viel F, McLaughlin T, Jarandehei A, Miller M, Falconnet D, White AK, Kent DG, Copley MR, Taghipour F, Eaves CJ, Humphries RK, Piret JM, Hansen CL.

Nat Methods. 2011 May 22;8(7):581-6. doi: 10.1038/nmeth.1614.

PMID:
21602799
18.

Ubiquitous expression of the monomeric red fluorescent protein mCherry in transgenic mice.

Fink D, Wohrer S, Pfeffer M, Tombe T, Ong CJ, Sorensen PH.

Genesis. 2010 Dec;48(12):723-9. doi: 10.1002/dvg.20677. Epub 2010 Nov 19.

PMID:
20853428
19.

Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.

Boehm A, Walcherberger B, Sperr WR, Wöhrer S, Dieckmann K, Rosenmayr A, Pernicka E, Fischer G, Worel N, Mitterbauer G, Schwarzinger I, Mitterbauer M, Haas OA, Lechner K, Hinterberger W, Valent P, Greinix HT, Rabitsch W, Kalhs P.

Biol Blood Marrow Transplant. 2011 Jan;17(1):133-40. doi: 10.1016/j.bbmt.2010.06.019. Epub 2010 Jul 1.

20.

Supplemental Content

Loading ...
Support Center